🟢 Humacyte is trading 5.3% up; no clear catalyst identified

Humacyte is trading 5.27% up at $0.38 on October 14, 2026, with no clear company-specific catalyst identified.

• The Phase 3 V012 presentation announcement was made October 12, not October 14.
• Biotech shares are down as hotter-than-expected annual inflation and higher-rate concerns pressure markets; this backdrop does not clearly explain Humacyte’s gain.